Chemoinformaics analysis of 6,10,14-TRIMETHYL-PENTADECAN-2-ONE
| Molecular Weight | 268.485 | nRot | 12 |
| Heavy Atom Molecular Weight | 232.197 | nRig | 1 |
| Exact Molecular Weight | 268.277 | nRing | 0 |
| Solubility: LogS | -6.454 | nHRing | 0 |
| Solubility: LogP | 6.477 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 55 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 54.8665 |
| nHD | 0 | BPOL | 36.9835 |
| QED | 0.423 |
| Synth | 3.005 |
| Natural Product Likeliness | 0.798 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.278 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.535 |
| MDCK | 0.00000997 |
| BBB | 0.634 |
| PPB | 0.982548 |
| VDSS | 1.556 |
| FU | 0.0215875 |
| CYP1A2-inh | 0.318 |
| CYP1A2-sub | 0.208 |
| CYP2c19-inh | 0.356 |
| CYP2c19-sub | 0.665 |
| CYP2c9-inh | 0.438 |
| CYP2c9-sub | 0.96 |
| CYP2d6-inh | 0.052 |
| CYP2d6-sub | 0.075 |
| CYP3a4-inh | 0.135 |
| CYP3a4-sub | 0.132 |
| CL | 6.822 |
| T12 | 0.136 |
| hERG | 0.032 |
| Ames | 0.003 |
| ROA | 0.009 |
| SkinSen | 0.923 |
| Carcinogencity | 0.039 |
| EI | 0.926 |
| Respiratory | 0.366 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.671724 |